Invasive Bladder Cancer
Also known as: Carcinoma of urinary bladder, invasive (disorder) / Malignant neoplasm of bladder, unspecified / Bladder neoplasms malignant / Malignant tumor of urinary bladder (disorder) / Malignant neoplasm of bladder / Bladder cancer / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11595 | Atezolizumab | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB11945 | Avelumab | 1 / 2 | Terminated | 1 |
| DB01101 | Capecitabine | 1 / 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 1 / 2 | Recruiting | 1 |
| DB00305 | Mitomycin | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Terminated | 1 |
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Terminated | 1 |
| DB11771 | Tremelimumab | 2 | Active Not Recruiting | 1 |
| DB00281 | Lidocaine | Not Available | Completed | 1 |